AI-generated summary
The authors pooled eight randomized controlled trials with 340 participants to assess photobiomodulation for pain and function in patellofemoral pain syndrome. They report that photobiomodulation was associated with reduced pain and improved function compared with control, though heterogeneity was high and the quality of evidence was rated very low. The authors call for standardized dosing and larger, higher-quality trials.
- Participants
- 340
- Studies included
- 8
- Who or what was studied
- Individuals with patellofemoral pain syndrome
- Limits stated in the abstract
- The abstract notes high risk of bias in five studies, substantial heterogeneity (I2 = 83%), very low quality of evidence, and the need for standardized dosing and larger trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objectives
The aim of this systematic review was to evaluate the effectiveness of photobiomodulation (PBM) on pain and function in individuals with Patellofemoral Pain Syndrome (PFPS).
Methods
A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Search was performed across PubMed/Midline, Scopus, Web of Science, EBSCO, ScienceDirect, Wiley Online Library, Springer, Cochrane CENTRAL, PEDro, ResearchGate, and Google Scholar from inception to January 2025. Randomized controlled trials (RCT) examining PBM in individuals with PFPS were included. Data extraction, risk-of-bias assessment (RoB 2), and quality of evidence evaluation (GRADE) were performed independently by multiple reviewers. Primary and secondary outcomes were pain and function, respectively. A random effect meta-analysis was performed to estimate the standardized mean difference (SMD) at 95% confidence interval (CI) and overall effect size.
Results
Eight trials (340 participants) met the inclusion criteria. PBM significantly reduced pain compared with the control (SMD = -0.83; 95% CI -1.40 to -0.27). Functional outcomes demonstrated a significant improvement favoring PBM (SMD = 0.68; 95% CI 0.08 to 1.27), although substantial heterogeneity was present (I2 = 83%). RoB2 showed five high-risk studies. GRADE showed a very low quality of evidence due to study limitations, imprecision, and inconsistency which limit the confidence to the effect estimate.
Conclusions
PBM, combined with exercise, provides improvements in pain and knee function in individuals with PFPS. While findings support PBM as an effective adjunct modality, standardized dosing protocols and larger, high-quality RCTs are needed to strengthen future clinical recommendations.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Meta-analysis, Photobiomodulation therapy, GRADE, Randomized controlled trial, Confidence interval, Heterogeneity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.